Take 10% off your next web order for ALL Life Science products with promo code: SHOPWEB10. Offer ends September 1st, 2020.
MP Biomedicals FastPrep® Instruments help expedite COVID-19 current vaccine research with INOVIO Pharmaceuticals, University of Oxford and CSIRO in Australia.
MP Biomedicals is proud to see the FastPrep-24 Classic has been instrumental in SARS-CoV-2 therapeutic research. INOVIO Pharmaceuticals, together with University of Oxford and researchers at Commonwealth Scientific and Industrial Research Organization (CSIRO) in Australia, were featured on 9 News Australia showcasing their COVID-19 vaccine development.
Jun 05, 2020
MP Biomedicals performed in-house validation for the pathogen detection in air filters using the FastPrep-24™ 5G which can be applicable in controlling the transmission of airborne coronavirus through air filters.Read more >
Mar 03, 2020
MP Biomedicals, a division of Valiant Co., Ltd., is stepping in to support scientists worldwide in understanding SARS-CoV-2 and discovering solutions to combat COVID-19.Read more >
Mar 06, 2019
Article in Genetic Engineering & Biotechnology, “High-Performance Density Gradient Media for Purification of Leukocytes from Blood”.
MP Bio describes formulations that isolate mononuclear and polymorphonuclear leukocytes with high yield and viability using Lymphocyte Separation Medium (LSM™), LymphoSep™, and Mono-Poly™ Resolving Medium.Read more >
Jan 23, 2018
MP Biomedicals Announces New Dedicated Clean Rooms for Animal and Non-Animal Products
MP Biomedicals, LLC announces the installation of dedicated cleanrooms for animal origin (AO) and non-animal origin (NAO) products in their Solon, Ohio, USA facility. The addition of the ISO Class 6 clean rooms continues an ongoing initiative to meet the stringent quality control and regulatory compliance standards vital for biopharmaceutical and bioprocessing applications.Read more >
Aug 23, 2017
MP Biomedicals has been approved for exports of bovine blood proteins into China. This approval, granted last month to 16 companies by the General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China (AQSIQ) allows MP Biomedicals to export its entire range of bovine blood proteins into China. These products are used in the Life Science market for the manufacture of therapeutic monoclonal antibodies, vaccines, infectious disease media, diagnostic kits, cell culture media and other research purposes.Read more >
Aug 16, 2017
MP Biomedicals LLC, a leading provider of life science reagents, fine chemicals and diagnostic products for over 50 years, has agreed to sell the assets of their Rapid Diagnostics division to LumiQuick Diagnostics Inc., a manufacturer of high quality point of care tests and other immunoassay kits.Read more >
Mar 18, 2016
We are pleased to announce MP Biomedicals is now part of the Valiant Family, the acquisition of 100% membership interest of MP Biomedicals was completed on March 18. Valiant is ideally suitable to support MP's business with experienced R & D team, rich manufacturing capacity and abundant funding.Read more >
Apr 02, 2009
MP Biomedicals LLC, manufacturer of the leading sample preparation system, FastPrep-24 has announced the availability of a new cryogenic lysis adapter, TeenCoolPrep. The adapter is designed for cryogenic lysis of medium to large scale RNA preparation from difficult to lyse samples. The adapter is the first cryogenic grinding, homogenization and lysis adapter to be used specifically for standard 15ml tubes.Read more >